OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Peer-reviewed Prostate Cancer Research in the Department of Defense Appropriations Act, 2018

Floor Speech

Date: Sept. 6, 2017
Location: Washington, DC
Issues: Health and Health Care

BREAK IN TRANSCRIPT

Mr. Speaker, Soto amendment, Soto number 20 to Division A, the Department of Defense Appropriations Act, 2018, moved $10 million from the Operation and Maintenance, Defense-Wide account to the Defense Health Program's Peer-Reviewed Prostate Cancer Research Program.

Prostate cancer is the most commonly diagnosed cancer in men and is the second most common cause of male death. In 2017, approximately 161,360 men in the U.S. will be diagnosed with prostate cancer and an estimated 26,730 will die from it.

The Prostate Cancer Research Program is a unique research program in that it prioritizes research that will lead to the elimination of death from prostate cancer while enhancing the well-being of men experiencing the impact of the disease.

I support funding prostate cancer research and thank my colleagues for their support of my amendment.

BREAK IN TRANSCRIPT


Source
arrow_upward